Factorial design
Authors:
- Alexandra M. AdamsAAAlexandra M. Adams
- Patrick M. McCarthyPMPatrick M. McCarthy
- Daniel W. NelsonDNDaniel W. Nelson
- 24 March 2023
- book chapter
- Published by Elsevier
- p. 315-320
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Optimization of Multicomponent Behavioral and Biobehavioral Interventions for the Prevention and Treatment of HIV/AIDSAIDS and Behavior, 2015
- Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 studyThe Lancet Oncology, 2015
- Impact of the Addition of Carboplatin and/or Bevacizumab to Neoadjuvant Once-per-Week Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide on Pathologic Complete Response Rates in Stage II to III Triple-Negative Breast Cancer: CALGB 40603 (Alliance)Journal of Clinical Oncology, 2015
- Factorial clinical trials: a new approach to phase II neuro-oncology studiesNeuro-Oncology, 2014
- Factorial ExperimentsAmerican Journal of Preventive Medicine, 2014
- Efficient Designs: Factorial Randomized TrialsJournal of Bone and Joint Surgery, 2012
- Multilevel factorial experiments for developing behavioral interventions: Power, sample size, and resource considerations.Psychological Methods, 2012
- Reporting of factorial trials of complex interventions in community settings: a systematic reviewTrials, 2011
- Design of experiments with multiple independent variables: A resource management perspective on complete and reduced factorial designs.Psychological Methods, 2009
- Analysis and Reporting of Factorial TrialsJAMA, 2003